Press releases //

IntegraGen Collaborating with FIRE-3 Clinical Trial Investigators to Study hsa-miR-31-3p Metastatic Colorectal Cancer Biomarker

IntegraGen announced a collaboration with investigators from the FIRE-3 clinical trial (AIO KRK-0306) to further study the oncology biomarker hsa-miR-31-3p, a microRNA whose expression has been shown to be associated with anti-EGFR effect in patients with metastatic colorectal cancer (mCRC) treated with anti-EGFR therapy.

Link to press (…)  » 

Press releases //

Results from sequencing of 193 liver tumors performed by IntegraGen identifies potential role of a new virus in the development of liver cancer

IntegraGen announces a publication in Nature Genetics reporting the role of adeno-associated virus type 2 (AAV2)  virus in the development of liver cancer. Professor Jessica Zucman-Rossi and her colleagues at Inserm Unit 1162 in Paris, supported by expert sequencing services from IntegraGen, identified the role of AAV2, a (…)  »